Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.410
+0.070 (2.10%)
Feb 19, 2026, 2:14 PM EST - Market open
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $189.6 million as of February 19, 2026. Its market cap has decreased by -34.89% in one year.
Market Cap
189.60M
Enterprise Value
-4.94M
1-Year Change
-34.89%
Ranking
Category
Stock Price
$3.41
Market Cap Chart
Since November 11, 2015, Voyager Therapeutics's market cap has decreased from $456.60M to $189.60M, a decrease of -58.48%. That is a compound annual growth rate of -8.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 185.70M | -15.01% |
| Dec 31, 2025 | 218.50M | -29.45% |
| Dec 31, 2024 | 309.70M | -16.59% |
| Dec 29, 2023 | 371.30M | 57.66% |
| Dec 30, 2022 | 235.50M | 128.86% |
| Dec 31, 2021 | 102.90M | -61.59% |
| Dec 31, 2020 | 267.90M | -48.20% |
| Dec 31, 2019 | 517.20M | 69.02% |
| Dec 31, 2018 | 306.00M | -31.60% |
| Dec 29, 2017 | 447.40M | 31.43% |
| Dec 30, 2016 | 340.40M | -41.89% |
| Dec 31, 2015 | 585.80M | 28.30% |
| Nov 11, 2015 | 456.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonix Pharmaceuticals Holding | 194.98M |
| Polaryx Therapeutics | 187.48M |
| Ovid Therapeutics | 186.16M |
| SAB Biotherapeutics | 184.71M |
| Crescent Biopharma | 182.40M |
| Tiziana Life Sciences | 177.40M |
| C4 Therapeutics | 177.35M |
| Molecular Partners AG | 177.03M |